Search

everythinglearnresearchcommunity

for

Search:↓

Oral tofacitinib shows promise in treating atopic dermatitis and alopecia areata, but only slight improvement in vitiligo.

Nearly half of the French individuals surveyed reported having a sensitive scalp, more common in women, often linked to hair loss and symptoms like itching, and triggered by factors including shampoos and pollution.

Combining diphenylcyclopropenone with anthralin is more effective for hair regrowth in alopecia areata than using diphenylcyclopropenone alone, but may cause more side effects.

Rat vibrissa follicles are useful for studying hair growth cycles, especially the transition from pro-anagen to anagen.

Baricitinib helped a woman with severe hair loss regrow almost all her hair without side effects.

Perilla frutescens, an East Asian plant, contains 400 bioactive compounds that have various health benefits, including anti-inflammatory, antidepressant, and anticancer effects, and can treat conditions like diabetes, skin allergies, and neurological disorders.

Using CD123 to detect certain immune cells helps diagnose a type of hair loss condition.

Immunomodulatory therapies are effective for treating cutaneous lymphoma, particularly in early stages.

Key genes linked to hair growth and cancer were identified in hairless mice.

Putting thymidine dinucleotide on newborn mice's skin can delay and reduce skin cancer.

Ecklonia cava improves the effectiveness of Diane-35 in managing PCOS symptoms.

JAK inhibitors effectively regrow hair in alopecia areata but hair loss often returns after stopping treatment.

Early recognition and a team approach are crucial for managing diffuse alveolar hemorrhage in antiphospholipid syndrome.

Alopecia areata patients may have higher T3 and cortisol levels, suggesting a hormonal link.

Latanoprost is more effective than minoxidil for treating alopecia areata.

Secukinumab can cause hair loss, which may improve after stopping the medication.

COVID-19 can cause intense hair loss in women, usually resolving in 1 to 4 months.

Higher IL-21 levels may help predict alopecia areata activity.

Prolactin levels and gene polymorphism are not linked to vitiligo severity but are related to BMI.

Tofacitinib is a potential alternative treatment for alopecia totalis, especially in patients with a shorter duration of the condition and more preserved hair follicles, but the overall response rate is low.

PDE inhibitors, especially PDE4 inhibitors like apremilast, are effective for certain inflammatory skin conditions but have side effects and can be costly.

Hidradenitis Suppurativa is likely an autoinflammatory disease, and better understanding its causes could improve treatments.

Acne vulgaris is a common skin condition that can cause low self-esteem and depression, and early treatment is important to prevent scarring.

The conclusion suggests a new treatment for infantile hemangiomas and a potential target for hair loss treatment.

UK medical students lack dermatology education, liver biopsy patients with risk factors show more fibrosis, and certain fungi resist drugs due to melanin; genetics may influence female hair loss.

Clascoterone is a new, effective, and safe acne treatment without systemic side effects.

Pterostilbene significantly reduces prostate enlargement and has strong antioxidant effects.

COVID-19 may cause early hair loss similar to classic temporary hair loss, with further research needed.

Ingenol mebutate gel changes gene expression related to skin development and immune response in actinic keratosis.

Gender-specific analysis could improve treatment for childhood systemic lupus erythematosus.